Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eman I El-Berri"'
Autor:
Eman El-Khateeb, Eman I. El-Berri, Esraa M. Mosalam, Mohamed Z. Nooh, Shimaa Abdelsattar, Amira M. Alghamdi, Sarah Alrubia, Mahmoud S. Abdallah
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Type 2 diabetes mellitus (T2DM) is common with obesity. Metformin is a first-line therapy for this condition. However, it has only a minor impact on weight loss in some patients.Aim: This study aimed to evaluate the effectiveness, tolerab
Externí odkaz:
https://doaj.org/article/ab8fabb54ec5483a9b9a4781012c558d
Autor:
Hend E. Abo Mansour, Aya Ibrahim Elberri, Mai El-Sayed Ghoneim, Waad A. Samman, Aisha A. Alhaddad, Mahmoud S. Abdallah, Eman I. El-Berri, Mohamed A. Salem, Esraa M. Mosalam
Publikováno v:
Molecules, Vol 28, Iss 18, p 6566 (2023)
Background: Alzheimer’s disease (AD) is a common neurodegenerative disorder without effective treatment. Thymoquinone (TQ) has demonstrated potential in exhibiting anti-inflammatory, anti-cancer, and antioxidant characteristics. Despite TQ’s neur
Externí odkaz:
https://doaj.org/article/3100f6042a7946f5a4ea37922b7f09ca
Autor:
Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan, Ahmed N. Ramadan, Hend Omara‐Reda, Abdel‐Aziz A. Zidan, Waad A. Samman, Eman I. El‐berri
Publikováno v:
CNS Neuroscience & Therapeutics. 29:354-364
The aim of this study was to explore the effectiveness and safety of pentoxifylline as an adjuvant to risperidone in mitigating the negative symptoms in patients with chronic schizophrenia.In this randomized, placebo-controlled study, eighty outpatie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d1d891f58368b8b6e609d4e27986d3
https://doi.org/10.1111/cns.14010
https://doi.org/10.1111/cns.14010
Publikováno v:
Medical Oncology. 38
The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for cancerous patients is an urgent need. Sixty newly diagnosed diffuse large B-cell lymphoma (DL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64daa1ccb1d3a11ee3d5705d3dafa483
https://doi.org/10.1007/s12032-020-01452-z
https://doi.org/10.1007/s12032-020-01452-z
Publikováno v:
Medical oncology (Northwood, London, England). 38(1)
The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for cancerous patients is an urgent need. Sixty newly diagnosed diffuse large B-cell lymphoma (DL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::686779702fb1c76511a5b2a0135cb55e
https://pubmed.ncbi.nlm.nih.gov/33394214
https://pubmed.ncbi.nlm.nih.gov/33394214